Targeting Msx2 as a brake in the fusion fate of osteoclasts and an anabolic therapy in pre-clinical models of osteoporosis

Journal:

Nature Communications

Published:

2025-08-06

DOI:

10.1038/s41467-025-61938-0

Affiliations:

7

Authors:

16

Go to article

Institutions	Authors	Share
Sir Run Run Shaw Hospital (SRRSH), Zhejiang University School of Medicine, China	13.666667 13.666667	0.85
Shanghai Ninth People's Hospital, SJTU, China	1.000000	0.06
The First Affiliated Hospital, USTC, China	0.666667	0.04
Qilu Hospital of Shandong University, China	0.333333	0.02
Xiangya Hospital, CSU, China	0.333333	0.02

Interested in Medicinal and Biomolecular Chemistry?